Phase I randomized trial of liothyronine for remyelination in multiple sclerosis: A dose-ranging study with assessment of reliability of visual outcomes
Lindsey Wooliscroft, Ghadah Altowaijri, Andrea Hildebrand, Mary H. Samuels, Barry Oken, Dennis Bourdette, Michelle Cameron
Topics & Concepts
MedicineDose-ranging studyTolerabilityAdverse effectPlaceboMultiple sclerosisRemyelinationClinical endpointClinical trialInternal medicineDouble blindPsychiatryMyelinCentral nervous systemAlternative medicinePathologyMultiple Sclerosis Research StudiesOphthalmology and Eye DisordersVestibular and auditory disorders